The successful employment of the HSV-tk gene for ovarian cancer gene therapy using HPV pseudovirions suggests that other suitable candidate genes may also be delivered by HPV pseudovirion to ovarian tumors for ovarian cancer gene therapy. Here, TKT is linked to ovarian cancer.